Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00635791
What this trial is testing

Phase I Study of Vorinostat and Sorafenib in Advanced Cancer

Who this might be right for
Malignant Solid TumourRenal Cell CarcinomaNon Small Cell Lung Carcinoma
University of Colorado, Denver 36
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Very early researchStudy completedNCT04678440
What this trial is testing

[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients

Who this might be right for
Lung Cancer, Nonsmall Cell
University of California, Davis 5
Not applicableNot Yet RecruitingNCT06832969
What this trial is testing

A Clinical Study of the Cryoablation Technique for Peripheral Lung Malignancies

Who this might be right for
Lung Cancer Patients
Guangzhou Medical University 10
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Early research (Phase 1)Study completedNCT00280982
What this trial is testing

Dendritic Cell-based Immunotherapy in Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Erasmus Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT05048082
What this trial is testing

Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies

Who this might be right for
Lung Cancer
OncoNano Medicine, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT03366103
What this trial is testing

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRecurrent Lung Small Cell CarcinomaRecurrent Malignant Solid Neoplasm+6 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00770120
What this trial is testing

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 61
Early research (Phase 1)Study completedNCT01680991
What this trial is testing

Obinutuzumab in Chinese Participants With CD20+ Malignant Disease

Who this might be right for
Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma
Hoffmann-La Roche 48
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Early research (Phase 1)Active Not RecruitingNCT03546426
What this trial is testing

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

Who this might be right for
Mesothelioma, MalignantPD-L1 NegativeAdvanced Cancer+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 18
Not applicableStudy completedNCT00639067
What this trial is testing

Breath Test for Early Detection of Lung Cancer

Who this might be right for
Lung Neoplasms
Menssana Research, Inc. 215
Early research (Phase 1)Study completedNCT01014598
What this trial is testing

Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis

Who this might be right for
Metastatic Malignant Neoplasm in the LungStage IIIB Non-Small Cell Lung CancerStage IV Adult Soft Tissue Sarcoma+1 more
Roswell Park Cancer Institute 11
Not applicableActive Not RecruitingNCT05228275
What this trial is testing

Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 549
Not applicableUnknownNCT02761863
What this trial is testing

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 100
Large-scale testing (Phase 3)Looking for participantsNCT05235165
What this trial is testing

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic OsteosarcomaOsteosarcoma
Children's Oncology Group 62
Testing effectiveness (Phase 2)Looking for participantsNCT06769295
What this trial is testing

A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC

Who this might be right for
Lung Cancer, Non-Small Cell
Sichuan University 28
Not applicableStudy completedNCT03597828
What this trial is testing

Respiratory Function of Dexmedetomidine in Patients Undergoing Pleuroscopy

Who this might be right for
Pleural Effusions, ChronicPleural Effusion, MalignantPleural Diseases
Attikon Hospital 60
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Next Page